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0929-6646/Copyright ª 2014, ElsevierBackground/Purpose: There has been no individual ultrasound feature of having high accuracy
for diagnosis of thyroid malignancy. In this study, we aimed to establish feature-oriented
criteria to characterize benign thyroid nodules that do not require ultrasound (US)-guided fine
needle aspiration (FNA).
Methods: We reviewed 374 patients with thyroid nodules who had undergone US-guided FNA at
our institution (2005e2008). Thyroid nodules were classified into two groups: Category 1 (benign
nodules that required follow-up 6e12 months later but not US-guided FNA); and Category 2
(indeterminate nodules or suspected carcinoma that required US-guided FNA). To test the valid-
ity, we reviewed 315 consecutive patients who had histologically proven thyroid carcinoma
(n Z 39) and randomly selected 40 of the 276 patients with benign nodules (2009e2010).
Results: Of 374 nodules, 354 (95%) were benign and 20 (5%) malignant. On US, 260 nodules had no
calcification, no increase in vascularity, well-defined margin, and no lymphadenopathy (Cate-
gory 1). Using a combination of these four features, we were able to discriminate benign from
indeterminate nodules or suspected malignant nodules with a sensitivity of 73%, and specificity
and positive predictive value of 100%. Validity testing revealed that none of the 39 malignant
thyroid nodules had all four US features. All Category 1 nodules (2005e2008) remained benign
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Sonographic features predictive of thyroid nodules 591Conclusion: The combination of four US features of Category 1 nodules is highly predictive of
benign disease, and we could avoid unnecessary US-guided FNA in 69.5% of our patients using this
combined features.
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Most thyroid nodules in adults are benign; the incidence of
malignancy has been reported to be 3e7%.1e4 Some thyroid
nodules can be detected at physical examination, but many
are incidental findings from imaging studies. Up to 67% of
thyroid nodules in adults are detected by ultra-
sonography.5e10 The most frequently used method of
diagnosis for thyroid nodules is ultrasound (US)-guided fine
needle aspiration (FNA), which has a low rate of compli-
cations. Use of US-guided FNA has led to a considerable
decrease in the number of surgical excisions and a twofold
increase in the diagnosis of carcinoma.1,3,4 Therefore, US-
guided FNA has replaced blind surgical excision, thereby
reducing the overall cost of medical care.11e14 However,
not every thyroid nodule detected on US is accessible to
aspiration.
Some authors advocate the use of a “classic pattern”
approach to evaluate malignant and benign nodules.1,6,15
The features of a malignant nodule on US can be a solid
hypoechoic mass, taller-than-wide shape, irregular shape,
spiculated margin, blurred or indistinct margin, micro- and
macrocalcifications, disrupted calcified rim, and intra-
nodular vascular pattern.6,16e24 The features of a benign
nodule on US can be isoechogenicity and spongiform
appearance, cystic with a colloid clot, and giraffe-like or
diffusely hyperechoic pattern.1,17 However, no single
appearance or combination of features are sufficiently
sensitive or specific for diagnosis of nodules imaged at
different centers.18 Also the interobserver reliability of
these features is variable.
The aim of this study was to establish feature-oriented
criteria to characterize benign thyroid nodules that do not
require US-guided FNA.Methods
The study protocol was approved by our institutional review
board. Informed consent was waived because of the
retrospective nature of this study and its limitation to the
analysis of data from patients’ records.
The study was divided into two parts. Between 2005 and
2008, the medical records of 538 consecutive patients with
thyroid nodules who had undergone US-guided FNA at our
institution were retrospectively reviewed. Patients who
had incomplete US images or whose cytopathology results
were inconclusive were excluded. Finally, 374 patients (298
women and 76 men; mean age, 50 years; range, 9e92
years) having complete medical records and US images
were recruited.
US examinations were performed on two scanners (ATL
Philips HDL 3000; Philips, Eindhoven, The Netherlands). US-guided FNA was routinely performed with a 21-gauge nee-
dle on a 10-mL syringe and at least three passes were made
per nodule. For a partially cystic nodule, the fluid was
aspirated with the needle directed at the solid portion of
the nodule. Specimens were smeared on four slides, two
fixed in 95% ethanol immediately and the other two dried in
room air. All pathological results were reported by senior
pathologists and the specimens were classified into benign,
atypical cell, or suspicious for follicular neoplasm or
papillary carcinoma.
Two senior radiologists with at least 6 years’ experi-
ence performing US reviewed the thyroid US images on a
picture archiving and communication system workstation.
The readers were blinded to clinical and pathologic
diagnosis, and reached a consensus interpretation. We
evaluated the nodular content (solid or cystic; Fig. 1A and
B), echogenicity (hyperechoic, isoechoic, or hypoechoic),
and calcification (micro, coarse, or absent; Fig. 1C and D).
Microcalcifications were too small to induce posterior
acoustic shadowing from echogenic foci with posterior
comet-tail artifacts (commonly seen in benign cystic or
partially cystic nodules; Fig. 1B).16,25 Nodular margin
(well-defined or ill-defined; Fig. 1A and E), vascularity
(increased or decreased) relative to the normal part of the
thyroid tissue (Fig. 1F), and lymph node hyperplasia or
lymphadenopathy (neck node with calcification or short-
axis longer than 10 mm; Fig. 1G and H) were also
evaluated.
Statistical analyses were performed using SPSS (SPSS
version 20, Inc., Chicago, IL, USA). The patient character-
istics and nodular size were analyzed by Fisher’s exact test.
The relative risk of malignancy was analyzed by logistic
regression. Statistical significance was accepted when the
corresponding p < 0.05. The sensitivity, specificity, positive
predictive value, and negative predictive value were
defined for each individual US feature in the detection of
benign masses.
Significantly different US features of benign thyroid
nodules were identified and used to divide thyroid nodules
into two groups: Category 1 (benign nodules that required
follow-up 6e12 months later but not US-guided FNA); and
Category 2 (indeterminate nodules or suspected carcinoma
that required US-guided FNA).
Between 2009 and 2010, there were 315 patients who
had received US-guided FNA for thyroid lesions and had
complete US images and medical records in our institution.
To perform validity testing of the US features indicating
benign disease, we reviewed the records of all consecutive
patients who had histologically proven thyroid carcinoma
(n Z 39) and randomly selected 40 of 276 patients with
benign nodules by including the first and second cases of
proven benign thyroid nodules in each month of a 2-year
period. The evaluation of clinical and histological
Figure 1 Individual ultrasound features of thyroid nodules. (A) A 62-year-old woman with a thyroid nodule. Transverse ultrasound
image of the left lobe of the thyroid shows a 1.8-cm isoechoic nodule with a halo, well-defined margin, and no calcification. The
cytological diagnosis was nodule with benign nonspecific cellular change. (B) A 74-year-old woman with a 2.4-cm thyroid nodule.
Transverse ultrasound image of the right lobe of the thyroid shows a hypoechoic area and comet-tail sign (arrow), indicating colloid
crystals, which should not be mistaken for microcalcifications. The cytological diagnosis was nodule with benign nonspecific
cellular change. (C) A 41-year-old woman with a thyroid nodule. Transverse ultrasound image of the left lobe of the thyroid shows a
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gists as before.
We also reviewed medical and US records, if any, of all
patients with Category 1 nodules (n Z 260, 2005e2008)
who had received 3 years of follow-up.Results
Of the 374 nodules, 354 (95%) were benign and associated
with diseases (including nodular goiter, Grave’s disease,
and Hashimoto’s thyroiditis), and 20 (5%) were malignant
[papillary carcinoma (nZ 18), follicular carcinoma (nZ 1),
and metastasis from cervical cancer (n Z 1)] proven on
cytopathology. Eighteen patients with malignancy were
referred for surgery and two patients were lost to follow-
up. There was no discrepancy between the initial
cytology and final pathologic results.
There was no significant difference in nodular size,
which was categorized as <1 cm (n Z 107), 1e2 cm
(nZ 162), and >2 cm (nZ 105; pZ 0.374; Table 1); mean
nodular size; patients’ age and sex; and multiplicity of
nodules between patients with benign lesions and patients
with malignant lesions (Table 2). The mean nodular size was
1.63 cm (range, 0.37e5.96 cm). US revealed a solitary
nodule in 56% (209/374) and two or more nodules in 44%
(165/374) of patients.
As compared to patients with malignant nodular thy-
roid disease, patients with benign nodular thyroid disease
had a significantly higher rate of nodules without calcifi-
cation than with coarse calcification and/or micro-
calcification (98%, 298/302 vs. 77%, 56/72; p < 0.001),
nodules with well-defined margin than with ill-defined
margin (99%, 310/312 vs. 71% , 44/62; p < 0.001), nod-
ules with a halo than without a halo (99%, 215/217 vs.
89%, 139/157; p < 0.001), nodules without increased
vascularity than with increased vascularity (96%, 340/354
vs. 70%, 14/20; p < 0.001), and nodules without lymph-
adenopathy than with lymphadenopathy (95%, 353/370 vs.
25%, 1/4; p < 0.001).
The between-group difference in the occurrence of
thyroid nodules with a halo was significant using the
Fisher’s exact test (p < 0.001) but was not significant
using logistic regression analyses. Logistic regression
analysis revealed significant between-group differences in
the absence of calcification [odds ratio (OR) 12.3,
p < 0.001], presence of well-defined margin (OR 35.4,
p < 0.001), absence of increase in vascularity (OR 6.7,
p < 0.001), and absence of lymphadenopathy (OR 104,
p < 0.001; Table 2).1.7-cm isoechoic nodule with a blurred margin and microcalcifica
carcinoma. (D) A 59-year-old woman with a 1.5-cm thyroid nodule
shows a hypoechoic area, blurred margin, and coarse calcification
cinoma. (E) A 71-year-old woman with a 1.0-cm thyroid nodule. Tran
hypoechoic area and blurred margin. The histological diagnosis wa
2.6-cm thyroid nodule. Transverse ultrasound image of the right lo
diagnosis was thyroid papillary carcinoma. (G) A 52-year-old woman
neck shows hypoechoic well-defined nodules. The cytological dia
woman with a 1.5-cm thyroid nodule. Transverse ultrasound image o
with microcalcification. The surgical diagnosis was thyroid papillarThe specificity of no calcification, no increase in vascu-
larity, well-defined margin, and no lymphadenopathy as
indicators of benign nodules was 80%, 30%, 90%, and 15%,
respectively (Table 3). Using a combination of these four
features, we were able to discriminate benign from ma-
lignant nodules with a sensitivity of 73%, specificity of 100%,
and positive predictive value of 100%.
A total of 260 benign nodules (69.5%) proven on cytology
were found to have all four US features: no calcification, no
increase in vascularity, well-defined margin, and no
lymphadenopathy (Fig. 2). Nodules with all of these US
features were classified as Category 1. By contrast, 114
thyroid nodules (30.5%) with one or more of the opposite US
features (including calcification, blurred margin, increase
in vascularity, and lymphadenopathy) were classified as
Category 2.
In Category 2 nodules, 16 out of 94 were proved to be
atypical by a second US-guided FNA within 3 years. Of these
16, seven nodules were referred for surgery; two were
papillary carcinoma and five were nodular goiters. These
two nodules (2/354, 0.5%) with microcalcification, hypo-
echoic echogenicity, well-defined margin, no increase in
vascularity, and no lymphadenopathy were initially diag-
nosed as benign by US-guided FNA cytology, atypical cell
disease 6 months later by a second US guided FNA, and
papillary cell carcinoma at surgery.
The results of our validity testing revealed that 18 out of
79 thyroid nodules (2009e2010) had all four Category 1
features. The other 61 nodules had one or more Category 2
features including micro- and/or macrocalcification
(n Z 37/79), blurred margin (n Z 46/79), increased
vascularity (nZ 23/79), and lymphadenopathy (3/79). Out
of 61 nodules (Category 2), 39 proved to be thyroid carci-
nomas. Using a combination of these four features, we
could discriminate benign from indeterminate nodules or
suspect malignant nodules with a sensitivity of 45%, speci-
ficity of 100%, positive predictive value of 100%, and
negative predictive value of 64%.
All Category 1 nodules (n Z 260, 2005e2008) remained
stable and benign at 3-years follow-up.Discussion
We found that no individual US feature had high sensitivity
and high specificity for detection of malignancy. Nonethe-
less, many of these previously described high-risk features,
such as taller-than-wide shape, irregular shape, spiculated
margin, blurred or indistinct margin, marked hypo-
echogenicity, micro- and macrocalcifications, disruptedtion (arrows). The histological diagnosis was thyroid papillary
. Transverse ultrasound image of the right lobe of the thyroid
(arrows). The histological diagnosis was thyroid papillary car-
sverse ultrasound image of the right lobe of the thyroid shows a
s thyroid papillary carcinoma. (F) A 47-year-old woman with a
be of the thyroid shows increased vascularity. The histological
with a thyroid nodule. Transverse ultrasound image of the left
gnosis was benign lymph node hyperplasia. (H) A 41-year-old
f the left neck shows a heterogeneous, hypoechoic lymph node
y carcinoma with lymphadenopathy.
Table 1 Size measured by ultrasound versus histological
diagnosis of thyroid nodules.
Nodule diameter
Histology <1 cm 1e2 cm >2 cm
Benign 101 151 102
Malignant 6 11 3
Papillary cancer 6 11 1
Follicular carcinoma 0 0 1
Metastasis 0 0 1
Total 107 162 105
c2 Z 1.967, p Z 0.374; there was no correlation between
diagnosis and nodular size.
594 S.-Y. Tay et al.calcified rim, and intranodular vascular pattern, were
frequently absent from nodules that required
aspiration.6,16e24 It has also been documented that hypo-
echoic nodules are an indicator of high risk for malig-
nancy.25 However, we found no significant difference in the
occurrence of single sonographic features between malig-
nant and benign nodules.
Thyroid calcifications, increased vascularity, and an ill-
defined margin may occur in both benign and malignant
disease.25 Previous reports have indicated that 29e59% of
all primary thyroid carcinomas contain micro-
califications16,18,23,25e27 and 69e74% of all thyroid malig-
nant tumors have increased vascularity.16,25,28 The
sensitivity of an ill-defined margin can vary widely (53e89%
and 7e97%, respectively).26e28 In our study, using a com-
bination of the four features, we were able to discriminate
benign from indeterminate nodules or suspected malignant
nodules with specificity of 100% and positive predictive
value of 100%.
Bonavita et al1 described the typical appearances of 10
sonographic features of thyroid nodules. They found that
reproducible patterns of thyroid nodule morphology, or
pattern recognition, rather than analysis of individual
sonographic features, were extremely accurate in the
identification of benign nodules. Each nodule was assigned
to one of 10 discrete morphologic groupings, including: (1)
spongiform without hypervascularity; (2) cyst with avas-
cular colloid plug; (3) giraffe pattern with blocks of
hyperechogenicity, or white, separated by bands of
hypoechogenicity, or black; (4) uniform hyperechogenicity
(“white knight”); (5) intense hypervascularity (“red
light”); (6) hypoechogenicity; (7) isoechogenicity without
a halo; (8) isoechogenicity with a halo; (9) “ring of fire”,
or nodules with intense peripheral vascularity; and (10)
other. Four patterns were identified as benign nodules
with 100% specificity: spongiform without hyper-
vascularity, cystic with avascular colloid plug, giraffe
pattern with blocks of hyperechogenicity, and uniform
hyperechogenicity.1 However, using 10 features to distin-
guish benign from malignant thyroid nodules is a difficult
and complicated task for inexperienced physicians in
clinical practice.
Kim et al29 investigated nonpalpable thyroid nodules
1e2 cm in diameter and advocated using US characteris-
tics significantly associated with malignancy, such asmicrocalcification, taller-than-wide shape, coarse calcifi-
cation, marked hypoechogenicity, speculated margin,
irregular shape, and hypoechogenicity; honeycomb
appearance was a significant characteristic of benign
nodules. However, 2% of malignant nodules (1 case) were
misdiagnosed and all of the malignant nodules were
diagnosed as papillary cell carcinoma; no other type of
thyroid malignant tumors were included. Yoon et al30
advocated using US-guided FNA to evaluate thyroid nod-
ules larger than 3 cm, with false-negative rates of
approximately 2%. A total of 29.7% of nodules with benign
US features finally proved to be malignant. Besides these
differences from our results, the studies of Kim et al29 and
Yoon et al30 differed from ours by lacking an analysis of
vascularity.
In our study, no thyroid nodules classified as Category 1
became malignant during the 3-year follow-up period,
therefore reaspiration of Category 1 thyroid nodules is
unnecessary. The American Thyroid Association guidelines
suggest clinical follow-up for 6e18 months, without US-
guided FNA for easily palpable benign nodules but with
repeat US-guided FNA or surgery for enlarging nodules
only.
Detection of malignancy is uncommon in repeat
ultrasound-guided FNA.31e33 In two studies of 250 patients
with benign nodules receiving repeat FNA, the second FNA
detected malignancy in only one previously diagnosed
benign nodule (0.4%). In a third study, 3 of 216 patients
(1.4%) had papillary cancer on repeat FNA. In our study, two
Category 2 nodules (having microcalcifications, without
increase vascularity, well-defined margin, and no lymph-
adenopathy) initially diagnosed as benign lesions by US-
guided FNA, but both were diagnosed as papillary carci-
noma in follow-up US-guided FNA 6 months later. There-
fore, thyroid nodules without combination of the four US
features (no calcification, no increase in vascularity, well-
defined margin, and no lymphadenopathy) should be clas-
sified as Category 2 and require US-guided FNA.
The 260 of 374 nodules (69.5%) classified as Category 1
based on the combination of four US features (no calcifi-
cation, no increase in vascularity, well-defined margin, and
no lymphadenopathy) were benign thyroid nodules.
Furthermore, we did not miss any malignant thyroid nod-
ules that were classified as Category 2. Our validity test
further identified benign thyroid nodules using the estab-
lished Category 1 features, providing both the specificity
and positive predictive value of 100% for diagnosis of benign
cytopathology. Therefore, US-guided FNA of these nodules
can be avoided.
One limitation of our study is that we did not use real-
time elastography to differentiate benign from malignant
thyroid nodules. Real-time elastography may enhance the
cancer-predictive value of noncystic, noncalcified thyroid
nodules.34 However, our combination of US features ad-
dresses the issue of screening and diagnosis of benign thy-
roid nodules with high specificity and positive predictive
value.
We conclude that the combination of four US features of
Category 1 nodules is highly predictive of benign disease,
and we could avoid unnecessary US-guided FNA in 69.5% of
our patients using these combined features.
Table 3 Sensitivity, specificity, positive predictive value, and negative predictive value of ultrasonographic characteristics of
benign thyroid nodules useful in avoiding unnecessary ultrasound-guided fine needle aspiration.
Ultrasonographic findings Sensitivity Specificity Positive predictive
value
Negative predictive
value
Accuracy
1. Well-defined margin 88 (310/354) 90 (18/20) 99 (310/312) 29 (18/62) 88 (328/374)
2. Without increase in vascularity 96% (340/354) 30 (6/20) 96 (340/354) 30 (6/20) 93 (346/374)
3. No lymphadenopathy 100 (353/354) 15 (3/20) 95 (353/370) 75 (3/4) 95 (356/374)
4. No calcification 84 (298/354) 80 (16/20) 99 (298/302) 22 (16/72) 84 (314/374)
Presence of all 4 items 73 (260/354) 100 (20/20) 100 (260/260) 18 (20/114) 75 (280/374)
Data are presented as % (n/N).
Table 2 Characteristics of malignant and benign thyroid nodules.
Characteristic Benign (%) Malignant (%) Total p Odds ratio
Patients, n 354 20 374
Age, y 52  15 51  12 50  14 0.800
Sex
Female 280 (79) 18 298 0.238
Male 74 (21) 2 76
Number of nodules
1 73 (21) 3 (15) 76 0.543
2 or more 281 (79) 17 (85) 298
Size of nodule, mean, cm 1.66  1.02 1.13  0.47 1.63  1.01 0.050
Echo structure
Solid 201 (57) 8 (40) 209 0.141
Cystic 153 (43) 12 (60) 165
Echogenicity
Hyperechoic 5 (1) 0 (0) 6 0.189
Isoechoic 127 (36) 4 (20) 131
Hypoechoic 222 (63) 16 (80) 237
Calcification
Micro 18 (5) 13 (65) 31 <0.001 12.3**
Coarse 37 (11) 2 (10) 39
Micro þ coarse 1 (0) 1 (5) 2
No calcification 298 (84) 4 (20) 302
Margin
Well-defined 310 (88) 2 (10) 312 <0.001 35.4***
Ill-defined 44 (12) 18 (90) 62
Halo
Absent 139 (39) 18 (90) 157 <0.001
Present 215 (61) 2 (10) 217
Heterogeneity
Cyst 60 (17) 0 60 0.068
Homogeneous 16 (4) 0 16
Heterogeneous 278 (79) 20 (100) 298
Vascularity
Absent 340 (96) 14 (70) 354 <0.001 6.7*
Present 14 (4) 6 (30) 20
Lymph node enlargement
Absent 353 (100) 17 (85) 370 <0.001 104*
Present 1 (0) 3 (15) 4
Data are presented as % of 354 patients with benign nodules or of 20 patients with malignant nodules.
*p < 0.05.
**p < 0.01.
***p < 0.001.
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Figure 2 Combined ultrasound features of thyroid nodules. A 45-year-old woman with a thyroid nodule. (A) Transverse view, (B)
sagittal view, and (C) color Doppler ultrasound image of the left lobe of the thyroid shows a 1.04-cm isoechoic nodule with cystic
component, well-defined margin, no calcification (white arrows), and decreased vascularity relative to the normal part of the
thyroid tissue. The patient had undergone subtotal thyroidectomy, and the histological finding was benign nodular goiter.
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